COMP <GO>
ROL vs PG // 10Y YIELD & FRED MACRO BETA
Rollins Inc. (NYSE) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: ROL 6
— PG 9
▲ 10Y YIELD & FRED MACRO BETA LEADER: ROL
LAST: $34.66 (-0.09%) • MKT CAP: $16.58B
macro-sensitivity
1.13
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
macro-sensitivity
0.87
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ROL VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ROL | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 51.20% | -10.20 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.50% | 25.40% | +3.10 | ROL | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.0x | 16.2x | +6.80 | PG | /valuation <GO> |
| Free Cash Flow Yield | 3.92% | 3.77% | +0.15 | ROL | /fcf-yield <GO> |
| Operating Margin | 19.30% | 24.30% | -5.00 | PG | /operating-margins <GO> |
| Net Profit Margin | 14.00% | 19.00% | -5.00 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 11.00% | 0.30% | +10.70 | ROL | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 1.98% | 2.65% | -0.67 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.80 | 5.59 | +2.21 | ROL | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ROL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.50% | +0.80 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 58.0 | 62.7 | -4.65 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.13 | 0.87 | +0.26 | ROL | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.3x | 21.7x | +7.60 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $16.58B | $372.21B | -$355.63B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ROL REV | PG REV | ROL GROSS % | PG GROSS % | ROL FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.76B | $84.28B | 44.0% | 51.2% | $650.0M | $14.04B |
| FY 2024 | $3.39B | $84.04B | 44.0% | 51.4% | $580.1M | $16.52B |
| FY 2023 | $3.07B | $82.01B | 44.0% | 44.0% | $390.1M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ROL // BETA 1.13
PG // BETA 0.87